This Article Full Text Full Text (PDF) All Versions of this Article: 22/7/1187    most recent 01.ATV.0000021759.08060.63v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sampson, M.J. Articles by Hughes, D.A. Search for Related Content PubMed PubMed Citation Articles by Sampson, M.J. Articles by Hughes, D.A. Related Collections Pathophysiology Risk Factors Mechanism of atherosclerosis/growth factors

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1187.)
© 2002 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Monocyte and Neutrophil Adhesion Molecule Expression During Acute Hyperglycemia and After Antioxidant Treatment in Type 2 Diabetes and Control Patients

M.J. Sampson; I.R. Davies; J.C. Brown; K. Ivory; D.A. Hughes

From Bertram Diabetes Research Unit (M.J.S., I.R.D.), Department of Diabetes & Endocrinology, Norfolk and Norwich University Hospital NHS Trust, and the Institute of Food Research (I.R.D., J.C.B., K.I, D.A.H.), Norwich Research Park, Colney, Norwich, UK.

Correspondence to M.J. Sampson, Department of Endocrinology and Diabetes, Norfolk and Norwich Hospital, Brunswick Road, Norwich NR1 3SR UK. E-mail mike.sampson{at}norfolk-norwich.thenhs.com

Objective— We hypothesized that acute hyperglycemia (an independent cardiovascular risk factor) increases the expression of proatherogenic leukocyte adhesion molecule in type 2 diabetes and controls and that the expression of these adhesion molecules would be antioxidant sensitive.

Methods and Results— Twenty-three type 2 diabetes patients and 13 control patients underwent two oral glucose tolerance tests 14 days apart and took placebo or 800 IU daily of oral alpha tocopherol between tests. Monocyte and neutrophil expression of adhesion molecules Mac-1, LFA-1 and 3, ICAM-1, and VLA-4 were measured at 0, 120, and 240 minutes by using laser flow cytometry. Baseline adhesion molecule expression did not differ between groups, but there was a rapid, highly significant increase (P<0.0001) in the intensity of monocyte Mac-1 expression after a glucose load in both groups. Alpha-tocopherol supplementation reduced only Mac-1 expression in the diabetes group (P=0.03).

Conclusions— Acute glycemic excursions of any degree cause highly significant, rapid increases in monocyte Mac-1 expression in type 2 diabetes patients and controls. Mac-1 mediates leukocyte vascular infiltration and is prothrombotic. These data suggest a mechanism for the link between glycemic excursions and increased vascular event rates.

Key Words: type 2 diabetes • monocyte • adhesion molecule • hyperglycemia • antioxidants

This article has been cited by other articles:

				I. D. Ignatova, R. M. Kostadinova, C. E. Goldring, A. R. Nawrocki, F. J. Frey, and B. M. Frey Tumor necrosis factor-{alpha} upregulates 11{beta}-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-{beta} in HepG2 cells Am J Physiol Endocrinol Metab, February 1, 2009; 296(2): E367 - E377. [Abstract] [Full Text] [PDF]

				A. Alipour, A. J.H. H.M van Oostrom, A. Izraeljan, C. Verseyden, J. M. Collins, K. N. Frayn, T. W.M. Plokker, J. W. F. Elte, and M. Castro Cabezas Leukocyte Activation by Triglyceride-Rich Lipoproteins Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 792 - 797. [Abstract] [Full Text] [PDF]

				W.-Y. Zhang, E. Schwartz, Y. Wang, J. Attrep, Z. Li, and P. Reaven Elevated Concentrations of Nonesterified Fatty Acids Increase Monocyte Expression of CD11b and Adhesion to Endothelial Cells Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 514 - 519. [Abstract] [Full Text] [PDF]

				M. J. Sampson, M. S. Winterbone, J. C. Hughes, N. Dozio, and D. A. Hughes Monocyte Telomere Shortening and Oxidative DNA Damage in Type 2 Diabetes Diabetes Care, February 1, 2006; 29(2): 283 - 289. [Abstract] [Full Text] [PDF]

				S. Walrand, C. Guillet, Y. Boirie, and M-P. Vasson In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions J. Leukoc. Biol., December 1, 2004; 76(6): 1104 - 1110. [Abstract] [Full Text] [PDF]

				J. W. Kent Jr, A. G. Comuzzie, M. C. Mahaney, L. Almasy, D. L. Rainwater, J. L. VandeBerg, J. W. MacCluer, and J. Blangero Intercellular Adhesion Molecule-1 Concentration Is Genetically Correlated With Insulin Resistance, Obesity, and HDL Concentration in Mexican Americans Diabetes, October 1, 2004; 53(10): 2691 - 2695. [Abstract] [Full Text] [PDF]

				P. Holvoet, S. B. Kritchevsky, R. P. Tracy, A. Mertens, S. M. Rubin, J. Butler, B. Goodpaster, and T. B. Harris The Metabolic Syndrome, Circulating Oxidized LDL, and Risk of Myocardial Infarction in Well-Functioning Elderly People in the Health, Aging, and Body Composition Cohort Diabetes, April 1, 2004; 53(4): 1068 - 1073. [Abstract] [Full Text] [PDF]

				S. Clement, S. S. Braithwaite, M. F. Magee, A. Ahmann, E. P. Smith, R. G. Schafer, and I. B. Hirsch Management of Diabetes and Hyperglycemia in Hospitals Diabetes Care, February 1, 2004; 27(2): 553 - 591. [Full Text] [PDF]

				V. D. Longo and C. E. Finch Evolutionary Medicine: From Dwarf Model Systems to Healthy Centenarians? Science, February 28, 2003; 299(5611): 1342 - 1346. [Abstract] [Full Text] [PDF]